Patents by Inventor Scott D. Gorman

Scott D. Gorman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SECURE VEHICLE TO VEHICLE PTC COMMUNICATION
    Publication number: 20240109564
    Abstract: A method is provided that can include activating at least two wireless communication channels in parallel, between a first wireless transceiver and a second wireless transceiver. Each of the at least two wireless communication channels can operate at a different radio carrier frequency, and the first wireless transceiver may be part of a first vehicle. The method can also include transmitting, by the first wireless transceiver, common information in parallel on the at least two wireless communication channels to the second wireless transceiver and deactivating the at least two wireless communication channels.
    Type: Application
    Filed: December 12, 2023
    Publication date: April 4, 2024
    Inventors: Padam Dhoj Swar, Carl L. Haas, Danial Rice, Rebecca W. Dreasher, Adam Hausmann, Matthew Steven Vrba, Edward J. Kuchar, James Lucas, Andrew Ryan Staats, Jerrid D. Chapman, Jeffrey D. Kernwein, Janmejay Tripathy, Stephen Craven, Tania Lindsley, Derek K. Woo, Ann K. Grimm, Scott Sollars, Phillip A. Burgart, James Allen Oswald, Shannon K. Struttmann, Stuart J. Barr, Keith Smith, Francois P. Pretorius, Craig K. Green, Kendrick Gawne, Irwin Morris, Joseph W. Gorman, Srivallidevi Muthusami, Mahesh Babu Natarajan, Jeremiah Dirnberger, Adam Franco
  • Humanized anti-CD3 specific antibodies
    Publication number: 20040202657
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Application
    Filed: December 23, 2003
    Publication date: October 14, 2004
    Applicant: BTG International Limited
    Inventors: Sarah L. Bolt, Michael R. Clark, Scott D. Gorman, Edward G. Routledge, Herman Waldman
  • Plasmid stabilization
    Patent number: 6743780
    Abstract: A system is described which utilizes a novel system of repressor titration for maintenance of a plasmid useful in gene therapy and production of a recombinant protein. The system utilizes a transformed host cell containing a plasmid including an operator susceptible to binding by a repressor expressed in trans, a first chromosomal gene encoding the repressor, and a second chromosomal gene that is functionally associated with an operator and essential for cell growth, wherein the plasmid is present in the cell in sufficient numbers to titrate the repressor such that the essential gene is expressed, thereby permitting cell growth.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: June 1, 2004
    Assignee: Cobra Biologics Limited
    Inventors: Julian A. J. Hanak, Steven G. Williams, Scott D. Gorman, David J. Sherratt
  • Humanized anti-CD3 specific antibodies
    Patent number: 6706265
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: March 16, 2004
    Assignee: BTG International Limited
    Inventors: Sarah L. Bolt, Michael R. Clark, Scott D. Gorman, Edward G. Routledge, Herman Waldmann
  • Humanized anti-CD3 specific antibodies
    Patent number: 5585097
    Abstract: Novel aglycosylated antibodies having a binding affinity for the CD3 antigen complex are of value for use in therapy, particularly in immunosuppression.
    Type: Grant
    Filed: November 8, 1993
    Date of Patent: December 17, 1996
    Assignee: British Technology Group Limited
    Inventors: Sarah L. Bolt, Michael R. Clark, Scott D. Gorman, Edward G. Routledge, Herman Waldmann